Isis Pharmaceuticals, Inc. (ISIS) Higher After Tops Q2 EPS by 9c
Tweet
Share
E-mailGet Alerts ISIS Hot Sheet
Price: $57.56 --0%
Financial Fact:
Total operating expenses: 94.82M
Today's EPS Names:
MAXN, CSTR, ACU, More
Financial Fact:
Total operating expenses: 94.82M
Today's EPS Names:
MAXN, CSTR, ACU, More
Join SI Premium – FREE
Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) are trading higher after the company reported Q2 EPS of ($0.01), $0.09 better than the analyst estimate of ($0.10). Revenue for the quarter came in at $47.3 million versus the consensus estimate of $40.06 million.
For earnings history and earnings-related data on Isis Pharmaceuticals, Inc. (ISIS) click here.
For earnings history and earnings-related data on Isis Pharmaceuticals, Inc. (ISIS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Growth isn't weak enough to truly undercut inflation pressures - BMO
- Oilfield firm SLB's profit rises on international drilling demand
- PayPal (PYPL) stock: Risk-reward 'finally looks favorable' says Deutsche Bank
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
